Dosage and administration
Apply to cleansed face and throat twice daily. Avoid eye area.
Apply to cleansed face and throat twice daily. Avoid eye area.
Drug Facts
Salicylic Acid (1.0%)
For external use only.
Do not use
When using this product
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Water/Aqua/Eau, Butylene Glycol, C12-15 Alkyl Benzoate, Isododecane, Potato Starch Modified, Silica, Hyssopus Officinalis Extract, Melissa Officinalis Leaf Extract, Echinacea Purpurea Extract, Enantia Chlorantha Bark Extract, Yeast Extract, Aesculus Hippocastanum (Horse Chestnut) Seed Extract, Salix Nigra (Willow) Bark Extract, Allantoin, Panthenol, Sodium PCA, Bisabolol, Niacinamide, Ammonium Glycyrrhizate, Zinc Gluconate, Caffeine, Biotin, Phospholipids, Magnesium Ascorbyl Phosphate, Camphor, Menthol, Hamamelis Virginiana (Witch Hazel) Water, Oleanolic Acid, Sodium Hydroxide, Potassium Cetyl Phosphate, Glyceryl Stearate, PEG-100 Stearate, Cetyl Alcohol, Xanthan Gum, Vinyl Dimethicone/Methicone Silsesquioxane Crosspolymer, Nylon-12, Glycerin, Disodium EDTA, Ethylhexylglycerin, Phenoxyethanol.
Call toll free
1-800-831-5150 in the US
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68479-808-00 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-abb8-f424-e053-dadaa90a57ce | Oil Control Lotion |
| 68479-808-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-abb8-f424-e053-dadaa90a57ce | Oil Control Lotion |
| 68479-808-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-abb8-f424-e053-dadaa90a57ce | Oil Control Lotion |
| 68479-808-04 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-abb8-f424-e053-dadaa90a57ce | Oil Control Lotion |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68479-808-00 | Oil Control | 2 mL in 1 POUCH | LOTION | 2 | 2 | |
| 68479-808-01 | Oil Control | 22 mL in 1 BOTTLE | LOTION | 22 | 2 | |
| 68479-808-02 | Oil Control | 1 in 1 CARTON | LOTION | 1 | 2 | |
| 68479-808-02 | Oil Control | 60 mL in 1 BOTTLE | LOTION | 60 | 2 | |
| 68479-808-04 | Oil Control | 177 mL in 1 BOTTLE | LOTION | 177 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Salicylic Acid | ACTIVE INGREDIENT | O414PZ4LPZ | 2 | |
| Salicylic Acid | ACTIVE MOIETY | O414PZ4LPZ | 2 | |
| Alkyl (C12-15) Benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 2 | |
| Allantoin | INACTIVE INGREDIENT | 344S277G0Z | 2 | |
| Ammonium Glycyrrhizate | INACTIVE INGREDIENT | 3VRD35U26C | 2 | |
| Annickia Chlorantha Bark | INACTIVE INGREDIENT | H70115MP4A | 2 | |
| Biotin | INACTIVE INGREDIENT | 6SO6U10H04 | 2 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 2 | |
| Caffeine | INACTIVE INGREDIENT | 3G6A5W338E | 2 | |
| Camphor (Synthetic) | INACTIVE INGREDIENT | 5TJD82A1ET | 2 | |
| Cetyl Alcohol | INACTIVE INGREDIENT | 936JST6JCN | 2 | |
| Echinacea Purpurea | INACTIVE INGREDIENT | QI7G114Y98 | 2 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | 2 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 2 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| Glyceryl Monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 2 | |
| Hamamelis Virginiana Top Water | INACTIVE INGREDIENT | NT00Y05A2V | 2 | |
| Horse Chestnut | INACTIVE INGREDIENT | 3C18L6RJAZ | 2 | |
| Hyssopus Officinalis Flowering Top | INACTIVE INGREDIENT | X7HKN4FOJI | 2 | |
| Isododecane | INACTIVE INGREDIENT | A8289P68Y2 | 2 | |
| Levomenol | INACTIVE INGREDIENT | 24WE03BX2T | 2 | |
| Magnesium Ascorbyl Phosphate | INACTIVE INGREDIENT | 0R822556M5 | 2 | |
| Melissa Officinalis Leaf | INACTIVE INGREDIENT | 50D2ZE9219 | 2 | |
| Menthol, Unspecified Form | INACTIVE INGREDIENT | L7T10EIP3A | 2 | |
| Niacinamide | INACTIVE INGREDIENT | 25X51I8RD4 | 2 | |
| Nylon-12 | INACTIVE INGREDIENT | 446U8J075B | 2 | |
| Oleanolic Acid | INACTIVE INGREDIENT | 6SMK8R7TGJ | 2 | |
| Omega-3 Fatty Acids | INACTIVE INGREDIENT | 71M78END5S | 2 | |
| Panthenol | INACTIVE INGREDIENT | WV9CM0O67Z | 2 | |
| PEG-100 Stearate | INACTIVE INGREDIENT | YD01N1999R | 2 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 2 | |
| Potassium Cetyl Phosphate | INACTIVE INGREDIENT | 03KCY6P7UT | 2 | |
| Salix Nigra Bark | INACTIVE INGREDIENT | QU52J3A5B3 | 2 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 2 | |
| Sodium Pyrrolidone Carboxylate | INACTIVE INGREDIENT | 469OTG57A2 | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 | |
| Xanthan Gum | INACTIVE INGREDIENT | TTV12P4NEE | 2 | |
| Yeast, Unspecified | INACTIVE INGREDIENT | 3NY3SM6B8U | 2 | |
| Zinc Gluconate | INACTIVE INGREDIENT | U6WSN5SQ1Z | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68479-808 | 68479-808-02, 68479-808-01, 68479-808-04, 68479-808-00 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL / TOPICAL | 1.16 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / SOFT TISSUE | 1 mg | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | LIQUID / NASAL | 2 mg/1ml | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INFILTRATION | 6 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / OPHTHALMIC | 4 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, COATED PELLETS / ORAL | 0.01 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / ORAL | 30 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / VAGINAL | 140 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / SUBCUTANEOUS | 1 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | LOTION / TOPICAL | 0.3 %w/v | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| Caffeine | CAFFEINE | 3G6A5W338E | SPRAY, METERED / NASAL | 10 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / SUBLINGUAL | 1.23 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRADERMAL | ADJ PH | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET / ORAL | NA | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRALESIONAL | ADJ PH | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, EXTENDED RELEASE / ORAL | 529 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRAVESICAL | ADJ PH | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 36 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INFILTRATION | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / TOPICAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / SUBMUCOSAL | ADJ PH | ||
| Menthol, Unspecified Form | MENTHOL | L7T10EIP3A | CAPSULE / ORAL | 0.87 mg | ||
| Menthol, Unspecified Form | MENTHOL | L7T10EIP3A | TABLET, ORALLY DISINTEGRATING / ORAL | 14 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | POWDER / INTRAVENOUS | ADJ PH | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | CONCENTRATE / ORAL | 20 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / TOPICAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING / ORAL | 0.15 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | TABLET, EXTENDED RELEASE / ORAL | 13 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / RECTAL | 17 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED / ORAL | NA | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 0.35 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | GEL, METERED / TRANSDERMAL | 350 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | AEROSOL, METERED / RESPIRATORY (INHALATION) | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | POWDER, FOR SUSPENSION / ORAL | 9 mg | ||
| Sodium Pyrrolidone Carboxylate | SODIUM PYRROLIDONE CARBOXYLATE | 469OTG57A2 | LOTION / TOPICAL | 42 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | POWDER / ORAL | 275 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 69 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9be73424-6777-43b6-b8e1-ab0e425bf3dd | b0c02c45-efa6-4ad6-992c-8bd8f1c43516 | 2015-11-20 | Warnings | 9be73424-6777-43b6-b8e1-ab0e425bf3dd b0c02c45-efa6-4ad6-992c-8bd8f1c43516 |
Adverse event summaries are temporarily unavailable. Other product information remains available.